CPC A01N 25/34 (2013.01) [A01N 25/02 (2013.01); A01N 47/44 (2013.01); A01N 59/16 (2013.01); A61K 8/19 (2013.01); A61K 8/84 (2013.01); A61P 31/04 (2018.01); A61P 31/12 (2018.01)] | 14 Claims |
1. An aqueous solution comprising an antibacterial and antiviral composition containing VOSO4, K11H[(VO)3(SbW9O33)2], Na9[SbW9O33], and polyhexamethylene biguanide as the only compounds having antibacterial or antiviral activity in the antibacterial and antiviral composition,
wherein in the antibacterial and antiviral composition:
the compounding ratio of VOSO4 is 0.1 to 20 M,
the compounding ratio of Na9[SbW9O33] is 0.1 to 30 M, and
the compounding ratio of polyhexamethylene biguanide is 0.1 to 30 M, with respect to 1 M of K11H[(VO)3(SbW9O33)2], and
wherein the aqueous solution comprises:
1 to 50 μg/mL VOSO4,
10 to 300 μg/mL K11H[(VO)3(SbW9O33)2],
50 to 1500 μg/mL Na9[SbW9O33], and
1 to 100 μg/mL polyhexamethylene biguanide.
|